Humanized antibody (similar to DF3) for CA15-3 capture and detection in FIA/CLIA applications. Used to observe breast cancer recurrence after treatment, monitor metastasis, and improve early diagnosis sensitivity when combined with other markers.
Manufactured by
Shenzhen, Guangdong, China
HeavyBio Inc. is a young expert in IVD raw materials for cardiac markers, tumor markers, inflammatory markers, neuroendocrine and infectious diseases, which has been committed to becoming the world's leading IVD reagent supplier since 2017. Based in Shenzhen, China, the company develops, manufactures and commercializes high-quality monoclonal antibodies, recombinant antibodies, antigens, etc., which are widely used in ELISA, CLIA, latex and rapid test platforms. Innovation and quality are our top priorities, market and customer orientation are our constant endeavors. HeavyBio Inc. has been at the forefront of fighting the Covid-19 pandemic since 2020, thanks to a professional team of more than 60% R D and technical service experts, which has earned a good reputation in the IVD field in China. HeavyBio Inc. is your trusted Chinese IVD solution provider and raw material specialist!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
J. Mitra & Co. Pvt. Ltd.
India · 1 relevant product
Boditech Med Inc.
South Korea · 3 relevant products
Medix Biochemica Oy AB
Finland · 2 relevant products
VEDALAB SAS
France · 5 relevant products
MedLevensohn
Brazil · 1 relevant product
Fujirebio Diagnostics,Inc.
China · 5 relevant products
Healgen Scientific LLC
United States · 1 relevant product
BiosPacific
United States · 3 relevant products
EPITOPE DIAGNOSTICS, INC.
United States · 10 relevant products
Bore Da Biotech Co., Ltd.
South Korea · 7 relevant products
18 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 74 closest product alternatives
J. Mitra & Co. Pvt. Ltd. · India
Tumor marker assay kit for CA19-9 detection using chemiluminescence immunoassay. Analytical sensitivity of 1.50 U/mL with linearity from 1.50 to 1000 U/mL.
Boditech Med Inc. · South Korea
A cancer biomarker reagent useful in the management and monitoring of breast cancer.
Medix Biochemica Oy AB · Finland
A diagnostic test for measuring Cancer Antigen 15-3 (CA15-3) levels in blood samples. This test is used in clinical laboratories for assessment and monitoring of breast cancer.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 15-3 (CA 15-3) in whole blood, serum or plasma. Measuring range: 5-200 IU/mL. Reading time: 10 minutes.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 15-3 (CA 15-3) in whole blood, serum or plasma. Measuring range: 5–200 IU/mL. Reading time: 10 minutes.
MedLevensohn · Brazil
A rapid diagnostic test for detecting CA15-3 antigen, a tumor marker commonly used in breast cancer monitoring and diagnosis.
Fujirebio Diagnostics,Inc. · China
An in vitro diagnostic test kit for the detection of cancer antigen 15-3 (CA15-3), a tumor marker. The product is CE certified and complies with European in vitro diagnostic product directive 98/79/EC. It is manufactured by ISO13485 certified facilities in Gothenburg, Sweden and Malvern, Pennsylvania, USA.
Healgen Scientific LLC · United States
CLIA-waived rapid immunofluorescence assay (FIA) test kit for qualitative detection of fentanyl in oral fluid samples. Enables quick screening in clinical and point-of-care settings with 510(k) clearance for reliable drug presence identification.
BiosPacific · United States
High-quality antibodies for CA19-9 cancer marker detection and immunoassay development. Essential for pancreatic and gastrointestinal cancer diagnostics.
BiosPacific · United States
Affinity purified antibodies for CA-125 biomarker detection in cancer diagnostics. Supports immunoassay platforms for ovarian and other cancer monitoring.
Boditech Med Inc. · South Korea
A diagnostic test reagent that supports the diagnosis of pancreatic cancer.
Fujirebio Diagnostics,Inc. · China
An in vitro diagnostic test kit for the detection of cancer antigen 19-9 (CA19-9), a tumor marker. The product is CE certified and complies with European in vitro diagnostic product directive 98/79/EC. It is manufactured by ISO13485 certified facilities in Gothenburg, Sweden and Malvern, Pennsylvania, USA.
62 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products